BioForce OÜ

14247974

General info

Name

BioForce OÜ

Registry code

14247974

VAT number

EE101981235

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

25.04.2017 (7)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

4120 - Construction of residential and non-residential buildings

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

-

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Bioforce Group OÜ

16260737

100% - 2 500.00 EUR - -

Egert Akenpärg

- Board member -

Henry Uljas

- Board member -

ICP Solutions OÜ

11659535

- - - Founder

Related companies

Owner Representative Beneficial owner Roles

Bioforce Infra OÜ

14772628

56% - 1 400.00 EUR - - Founder

Bioforce Kihnu OÜ

16666698

- - - Founder

Bioforce H OÜ

16125399

- - - Founder

Bioforce Production OÜ

16119754

- - - Founder

Bioforce Services OÜ

14798674

- - - Founder

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q4 2 966 697.77 € 311 508.26 € 31 662.21 € 5
2024 Q3 3 251 572.88 € 212 784.66 € 30 592.95 € 5
2024 Q2 3 694 555.67 € 276 830.03 € 30 852.21 € 5
2024 Q1 2 524 397.87 € 199 886.64 € 28 606.55 € 5
2023 Q4 250 831.47 € - 19 935.11 € 3
2023 Q3 1 067 003.01 € 133 943.65 € 23 797.36 € 3
2023 Q2 3 481 598.11 € 271 628.97 € 23 230.55 € 4
2023 Q1 3 052 627.31 € 523 306.1 € 29 916.46 € 4
2022 Q4 3 951 317.36 € 243 901.78 € 23 203.56 € 4
2022 Q3 2 556 654.97 € 115 388.48 € 21 730.95 € 4
2022 Q2 1 275 805.93 € 43 648.41 € 20 424.72 € 4
2022 Q1 1 501 146.07 € 180 767.59 € 14 106.31 € 4
2021 Q4 1 226 717.33 € 39 160.33 € 11 967.42 € 3
2021 Q3 4 637 211.69 € 387 177.95 € 10 038.35 € 3
2021 Q2 1 851 624.65 € 213 696.22 € 4 602.11 € 2
2021 Q1 1 099 650.09 € 140 748.64 € 4 409.76 € 1
2020 Q4 1 544 981.93 € 48 241.91 € 3 748.29 € 1
2020 Q3 993 421.2 € 150 594.3 € 3 748.29 € 1
2020 Q2 63 133.33 € 2 452.32 € 3 748.29 € 1
2020 Q1 - - - 1